Invex

IXC.AX

Tags: AU Healthcare Biotechnology

Invex Therapeutics Ltd Price (IXC.AX)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

75,312,339

(0.2109)%

Market Cap of Invex (IXC.AX)

Market cap:

As of , IXC.AX has a market cap of . This makes IXC.AX the 1583th most valuable company in the AU by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury that has completed Phase II clinical trial. The company was incorporated in 2019 and is based in Perth, Australia. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $0.059-0.09
Market Cap 5.26M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Ms. Narelle Warren B.Com, B.Com., L.L.B., LLB
IPO Date: July, 05, 2019
Country: AU
Currency: AUD
Headquaters: Perth, WA
Employees: No Data

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: